134 related articles for article (PubMed ID: 10699995)
41. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
[TBL] [Abstract][Full Text] [Related]
42. Loss of heterozygosity and methylation of p16 in renal cell carcinoma.
Sanz-Casla MT; Maestro ML; del Barco V; Zanna I; Moreno J; Vidaurreta M; Almansa I; Fernández C; Blanco J; Maestro C; Resel L
Urol Res; 2003 Jul; 31(3):159-62. PubMed ID: 12883879
[TBL] [Abstract][Full Text] [Related]
43. Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma.
Matsuura K; Shiga K; Yokoyama J; Saijo S; Miyagi T; Takasaka T
Anticancer Res; 1998; 18(1A):453-8. PubMed ID: 9568119
[TBL] [Abstract][Full Text] [Related]
44. Allelic deletions in renal tumors: histopathological correlations.
Presti JC; Reuter VE; Cordon-Cardo C; Mazumdar M; Fair WR; Jhanwar SC
Cancer Res; 1993 Dec; 53(23):5780-3. PubMed ID: 8242636
[TBL] [Abstract][Full Text] [Related]
45. Molecular evidence supporting field effect in urothelial carcinogenesis.
Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
[TBL] [Abstract][Full Text] [Related]
46. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Clin Cancer Res; 2000 May; 6(5):1819-25. PubMed ID: 10815903
[TBL] [Abstract][Full Text] [Related]
47. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer.
Perinchery G; Bukurov N; Nakajima K; Chang J; Li LC; Dahiya R
Int J Cancer; 1999 Nov; 83(5):610-4. PubMed ID: 10521795
[TBL] [Abstract][Full Text] [Related]
48. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas.
Druck T; Kastury K; Hadaczek P; Podolski J; Toloczko A; Sikorski A; Ohta M; LaForgia S; Lasota J; McCue P
Cancer Res; 1995 Nov; 55(22):5348-53. PubMed ID: 7585599
[TBL] [Abstract][Full Text] [Related]
49. Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences.
Kovacs G; Tory K; Kovacs A
J Pathol; 1994 May; 173(1):39-44. PubMed ID: 7931836
[TBL] [Abstract][Full Text] [Related]
50. Loss of heterozygosity of DNA repair gene, hOGG1, in renal cell carcinoma but not in renal papillary adenoma.
Gokden N; Li L; Zhang H; Schafer RF; Schichman S; Scott MA; Smoller BR; Fan CY
Pathol Int; 2008 Jun; 58(6):339-43. PubMed ID: 18477212
[TBL] [Abstract][Full Text] [Related]
51. Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma.
Palmedo G; Fischer J; Kovacs G
Lab Invest; 1999 Mar; 79(3):311-6. PubMed ID: 10092067
[TBL] [Abstract][Full Text] [Related]
52. Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes.
Wada T; Berggren P; Steineck G; Adolfsson J; Wijkström H; Norming U; Hansson J; Hemminki K; Larsson P
Scand J Urol Nephrol; 2003; 37(2):106-11. PubMed ID: 12745717
[TBL] [Abstract][Full Text] [Related]
53. Multifocal renal cancer: genetic basis and its medical relevance.
Bottaro DP; Linehan WM
Clin Cancer Res; 2005 Oct; 11(20):7206-8. PubMed ID: 16243789
[No Abstract] [Full Text] [Related]
54. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
[TBL] [Abstract][Full Text] [Related]
55. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas.
Kumar R; Smeds J; Lundh Rozell B; Hemminki K
Melanoma Res; 1999 Apr; 9(2):138-47. PubMed ID: 10380936
[TBL] [Abstract][Full Text] [Related]
56. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
[TBL] [Abstract][Full Text] [Related]
57. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
58. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
Hughson MD; Meloni A; Dougherty S; Silva FG; Sandberg AA
Cancer Genet Cytogenet; 1996 Apr; 87(2):133-9. PubMed ID: 8625259
[TBL] [Abstract][Full Text] [Related]
59. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
[TBL] [Abstract][Full Text] [Related]
60. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1053-9. PubMed ID: 14559990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
